1

Helping The others Realize The Advantages Of ABBV-744 in clinical trials for non-small cell lung cancer (NSCLC)

News Discuss 
Participant consumed grapefruit or grapefruit solutions within 3 days ahead of the initial dose of study drug. - Participant eaten grapefruit or grapefruit merchandise within 3 times ahead of the initial dose of study drug. In Segment C, contributors will get ABBV-744 and oral navitoclax. In Section D, participants will https://dicku099fqb1.activosblog.com/profile

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story